SEC Form 4 · accession 0001077183-19-000029
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn B McKenzie
Officer — Principal Accounting Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2019 | A | 2,273 | $0.00 | A | 2,273 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $19.60 | Mar 1, 2019 | A | 13,894 | A | Mar 1, 2020 | Mar 1, 2024 | Common Stock | 13,894 | 13,894 | D |
| Stock Option (Right to Buy)F2 | $8.03 | holding | — | — | — | Feb 26, 2019 | Feb 26, 2023 | Common Stock | 48,000 | 48,000 | D |
| Stock Option (Right to Buy)F3 | $9.07 | holding | — | — | — | Oct 18, 2018 | Oct 18, 2022 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1On March 1, 2019, Ms. McKenzie was granted an option to purchase 13,894 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.
- F2On February 26, 2018, Ms. McKenzie was granted an option to purchase 48,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.
- F3On October 18, 2017, Ms. McKenzie was granted an option to purchase 25,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.